ASLAN Pharmaceuticals to raise about $18m in a private placement

Singapore-based ASLAN Pharmaceuticals, a drug developer, has agreed to raise about $18 million in a private placement.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this